2020
DOI: 10.3390/ijms21113742
|View full text |Cite
|
Sign up to set email alerts
|

Effective Gold Nanoparticle-Antibody-Mediated Drug Delivery for Photodynamic Therapy of Lung Cancer Stem Cells

Abstract: Cancer stem cells (CSCs) are a leading contributor to lung cancer mortality rates. CSCs are responsible for tumor growth and recurrence through inhibition of drug-induced cell death, decreasing the effect of traditional cancer therapy and photodynamic therapy (PDT). PDT can be improved to successfully treat lung cancer by using gold nanoparticles (AuNPs), due to their size and shape, which have been shown to facilitate drug delivery and retention, along with the targeted antibody (Ab) mediated selection of CSC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
34
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
4
1

Relationship

2
8

Authors

Journals

citations
Cited by 59 publications
(35 citation statements)
references
References 77 publications
1
34
0
Order By: Relevance
“…Studies to further improve the effects of PDT and to make it specific are currently under study where clinical PS toxicity arising from non-specific uptake of PS drugs, along with a general question regarding the limited light penetration used for photoactivation in PDT, is under investigation. PDT can be directly aimed at cancerous cells by using nanoparticle and antibody conjugation of the PS, making it more specific and improving its absorption into cancer cells [ 28 ]. PDT may be used clinically with interstitial, endoscopic, intraoperative or laparoscopic light distribution devices with the use of fibres that can be placed at designated positions inside the tumour site due to developments in fibre optics and microendoscopic technology [ 82 ].…”
Section: Discussionmentioning
confidence: 99%
“…Studies to further improve the effects of PDT and to make it specific are currently under study where clinical PS toxicity arising from non-specific uptake of PS drugs, along with a general question regarding the limited light penetration used for photoactivation in PDT, is under investigation. PDT can be directly aimed at cancerous cells by using nanoparticle and antibody conjugation of the PS, making it more specific and improving its absorption into cancer cells [ 28 ]. PDT may be used clinically with interstitial, endoscopic, intraoperative or laparoscopic light distribution devices with the use of fibres that can be placed at designated positions inside the tumour site due to developments in fibre optics and microendoscopic technology [ 82 ].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it remains imperative to explore effective therapeutic approaches that may potentially improve prognosis in patients [3]. Photodynamic Therapy (PDT) is a promising noninvasive therapy for premalignant and neoplastic lesions, which is based on three essentials, namely visible light, oxygen, and photosensitizer (PS) [4]. The activation of photosensitizers (PSs) using a suitable wavelength of light, yields cytotoxic reactive oxygen species (ROS) and singlet oxygen, which in turn induce tumour cell death [5].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, samples with a PdI < 0.4 are considered homogeneous, >0.4 less homogeneous, and ≈1 completely heterogeneous [ 89 ]. The election of a threshold PdI value is still not consensual, with some stating values <0.3 as optimum [ 80 ], others considering values ≤0.5 still acceptable [ 90 ], and others setting the threshold as ≤0.7 [ 91 ]. In the present work, considering the PdI, both Ratios 1 and 2 are better than the remaining.…”
Section: Discussionmentioning
confidence: 99%